H.C. Wainwright Reiterates Buy Rating on Ocular Therapeutix (OCUL)

April 14, 2026 6:48 AM

H.C. Wainwright analyst Yi Chen reiterated a Buy rating and $21.00 price target on Ocular Therapeutix (NASDAQ: OCUL).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found